Immunotherapeutic effects of Mycobacterium tuberculosis rv3407 DNA vaccine in mice

References

• World Health Organization (WHO). Global tuberculosis report 2016. WHO/HTM/TB/2016.10. Geneva: World Health Organization; 2016. Available from: http://www.tbonline.info/posts/2016/10/16/global-tb-report-2016/.
   Google Scholar
• Dye C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J Am Med Assoc. 1999;282:677–686.
   PubMed Web of Science ®Google Scholar
• Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle. 1991;72:1–6.
   PubMedGoogle Scholar
• Corbett EL, Watt CJ, Walker N. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009–1021.
   PubMed Web of Science ®Google Scholar
• Cooper DKAM, Dalton TA, Stewart JP, et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993;178:2243–2247.
   PubMed Web of Science ®Google Scholar
• Flynn JL, Chan J, Triebold KJ, et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178:2249–2254.
   PubMed Web of Science ®Google Scholar
• Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb). 2004;84:93–101.
   PubMed Web of Science ®Google Scholar
• Yu D, Hu X, Cai H. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with combined DNA vaccines encoding Ag85B, MPT64 and MPT83. Gene Ther. 2008;15:652–659.
   PubMed Web of Science ®Google Scholar
• Liang Y, Wu X, Zhang J, et al. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Vaccine 2008;26:4536–4540.
   PubMed Web of Science ®Google Scholar
• Liang Y, Wu X, Zhang J, et al. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs. Scand J Immunol. 2011;74:42–46.
   PubMed Web of Science ®Google Scholar
• Ha SJ, Jeon BY, Kim SC, et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Ther. 2003;10:1592–1599.
   PubMed Web of Science ®Google Scholar
• Ha SJ, Jeon BY, Youn JI, et al. Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis. Gene Ther. 2005;12:634–638.
   PubMed Web of Science ®Google Scholar
• De, Souza GA, Leversen NA, Malen H, et al. Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway. J Proteomics. 2011;75:502–510.
   PubMed Web of Science ®Google Scholar
• Stanley BA, Shantz LM, Pegg AE. Expression of mammalian S-adenosylmethionine decarboxylase in Escherichia coli. Determination of sites for putrescine activation of activity and processing . J Biol Chem. 1994;269:7901–7907.
   PubMed Web of Science ®Google Scholar
• Kana BD, Gordhan BG, Downing KJ, et al. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol. Microbiol. 2008;67:672–684.
   PubMed Web of Science ®Google Scholar
• Downing KJ, Betts JC, Young DI, et al. Global expression profiling of strains harbouring null mutations reveals that the five rpf-like genes of Mycobacterium tuberculosis show functional redundancy. Tuberculosis (Edinb). 2004;84:167–179.
   PubMed Web of Science ®Google Scholar
• Zhao YJ, Bai XJ, Liang Y, et al. Prediction of epitopes of Mycobacterium tuberculosis Rv3407 protein. J Pathog Biol. 2014;9:486–488. (Chinese).
   Google Scholar
• Williams A, Hatch GJ, Clark SO, et al. Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinb). 2005;85:29–38.
   PubMed Web of Science ®Google Scholar
• Reece ST, Nasser-Eddine A, Dietrich J, et al. Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens. Vaccine. 2011;29:8740–8744.
   PubMed Web of Science ®Google Scholar
• Yu Q, Wang XC, Fan XL. A new adjuvant MTOM mediates Mycobacterium tuberculosis subunit vaccine to enhance Th1-Type T cell immune responses and IL-2+ T cells. Front Immunol. 2017;8:585.
   PubMed Web of Science ®Google Scholar
• Ma JL, Tian MP, Fan XL, et al. Mycobacterium tuberculosis multistage antigens confer comprehensive protection against pre- and post-exposure infections by driving Th1-type T cell immunity. Oncotarget. 2016;7:63804–63815.
   PubMedGoogle Scholar
• Mir FA, Kaufmann SHE, Eddine AN. A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire. Clin Vaccine Immunol. 2009;16:1467–1475.
   PubMed Web of Science ®Google Scholar
• Mollenkopf HJ, Grode L, Mattow J, et al. Application of Mycobacterial proteomics to vaccine design: improved protection by DNA boost vaccination against Mycobacterium bovis BCG prime-Rv3407. Infect Immun. 2004;72:6471–6479.
   PubMed Web of Science ®Google Scholar
• Sambrook J, EF, Fritsch T. Maniatis. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
   Google Scholar
• Wu X, Yang Y, Han Y, et al. Effect of recombinant Rv1009 protein on promoting the growth of Mycobacterium tuberculosis. J Appl Microbiol. 2008;105:1121–1127.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang X, Xiao L, et al. Immunogenicity and therapeutic effects of pVAX1-rv1419 DNA from Mycobacterium tuberculosis. CGT. 2016;16:249–255.
   Google Scholar
• Liang Y, Wu X, Zhang J, et al. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis. Fems Immunol Med Microbiol. 2012;66:419–426.
   PubMedGoogle Scholar
• Lowrie DB, Tascon RE, Bonato VLD, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature. 1999;400:269–271.
   PubMed Web of Science ®Google Scholar
• Manabe YC, Bishai WR. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med. 2000;6:1327–1329.
   PubMed Web of Science ®Google Scholar
• Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell. 1994;76:241–251.
   PubMed Web of Science ®Google Scholar
• Schuck SD, Mueller H, Kunitz F, et al. Identification of T-Cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS One. 2009;4:e5590.
   PubMed Web of Science ®Google Scholar
• Hoft DF, Blazevic A, Selimovic A, et al. Safety and immunogenicity of the recombinant BCG vaccine AERAS-422 in healthy BCG-naïve adults: a randomized, active-controlled, first-in-human phase 1 trial. EBio Med. 2016;7:278–286.
   PubMed Web of Science ®Google Scholar